Literature DB >> 16708064

Successful mobilization and transplantation of filgrastim mobilized hematopoietic stem cells in sickle cell-hemoglobin C disease.

R T Kamble, C K Tin-U, G Carrum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708064     DOI: 10.1038/sj.bmt.1705376

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

Review 1.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

2.  Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?

Authors:  Courtney D Fitzhugh; Matthew M Hsieh; Charles D Bolan; Carla Saenz; John F Tisdale
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

3.  Safety of pegfilgrastim (neulasta) in patients with sickle cell trait/anemia.

Authors:  Pashtoon Murtaza Kasi; Mrinal M Patnaik; Prema P Peethambaram
Journal:  Case Rep Hematol       Date:  2013-12-11

4.  Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion.

Authors:  Chantal Lagresle-Peyrou; François Lefrère; Elisa Magrin; Jean-Antoine Ribeil; Oriana Romano; Leslie Weber; Alessandra Magnani; Hanem Sadek; Clémence Plantier; Aurélie Gabrion; Brigitte Ternaux; Tristan Félix; Chloé Couzin; Aurélie Stanislas; Jean-Marc Tréluyer; Lionel Lamhaut; Laure Joseph; Marianne Delville; Annarita Miccio; Isabelle André-Schmutz; Marina Cavazzana
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.